HopeStage
Back to all studies
RecruitingISRCTN14487299

5 mg or 25 mg psilocybin with psychological support for generalized anxiety

About this title

A Phase IIb multicentre, randomised, double-blind, two-arm trial comparing the efficacy and safety of 25 mg psilocybin plus psychological support versus 5 mg psilocybin plus psychological support in adults with severe generalized anxiety disorder (GAD) (PSiGAD2)

Read the official source — ISRCTN14487299
Research studyAges 18–70United Kingdom
The study in practice

Understand this study

Who could participate?

This study is for people with anxiety. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Listed locations
United Kingdom

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Incannex Healthcare Limited
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Other / unclear
Locations
United Kingdom
Age range
From 18 Years to 70 Years
Official registry ID
ISRCTN14487299
Official title
Show the full official title

A clinical trial of 5 mg psilocybin plus psychological support vs 25 mg psilocybin plus psychological support in adults with generalised anxiety disorder

Recruitment & locations

Currently recruiting

United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Incannex Healthcare Limited.

Who can participate?

This study is for people with anxiety. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies